English, Article, Journal or magazine article edition: Survey of Pharmacoeconomic Assessment Activity in Eleven Countries Michael Dickson; Jeremy Hurst; Stéphane Jacobzone

User activity

Share to:
 
Bookmark: http://trove.nla.gov.au/version/146916
Physical Description
  • preprint
Language
  • English

Edition details

Title
  • Survey of Pharmacoeconomic Assessment Activity in Eleven Countries
Author
  • Michael Dickson
  • Jeremy Hurst
  • Stéphane Jacobzone
Physical Description
  • preprint
Notes
  • Policy-makers responsible for publicly-funded drug programmes face continual pressures between the demand to accommodate a steady stream of new and more effective drugs and the ongoing requirement to control costs. In the face of these pressures, a growing number of OECD countries are applying ‘pharmacoeconomic assessment’ (health technology assessment for drugs) - to new drugs to guide decisions about accepting such products for reimbursement under their public programme, or to inform negotiations about pricing. This paper provides an analytical overview of the developing practice of pharmacoeconomic assessment in eleven OECD countries. It looks at the objectives of the activity, some of its processes and some of its impacts. It does this by drawing on a literature review and on an exploratory survey of the activities of pharmacoeconomic agencies in the eleven countries. It also reviews briefly the state of pharmacoeconomic assessment in the United States. The main conclusions are as ... Les responsables des programmes et dispositifs assurant la couverture des frais pharmaceutiques à l'aide de fonds publics sont en permanence tiraillés entre une demande de prise en charge d'un flot incessant de médicaments nouveaux et plus efficaces et la nécessité constante d'une maîtrise des dépenses. Face à cette situation, un nombre croissant de pays de l'OCDE ont entrepris de soumettre les nouveaux médicaments à une "évaluation pharmacoéconomique" (évaluation des technologies de la santé appliquée aux médicaments) - pour fonder leur décision de déclarer ou non ces produits remboursables par leur dispositif public ou pour éclairer les négociations sur les prix. Le présent document donne une vue analytique d'ensemble de la pratique d'évaluation pharmacoéconomique, telle qu'elle commence à se développer dans onze pays de l'OCDE; Sont envisagés les objectifs de l'activité, quelques-unes des procédures mises en œuvre et certaines conséquences. Le rapport s'appuie sur une ...
  • RePEc:oec:elsaad:4-en
Language
  • English
Contributed by
OAIster

Get this edition

Other links

  • Set up My libraries

    How do I set up "My libraries"?

    In order to set up a list of libraries that you have access to, you must first login or sign up. Then set up a personal list of libraries from your profile page by clicking on your user name at the top right of any screen.

  • All (1)
  • Unknown (1)
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.

User activity


e.g. test cricket, Perth (WA), "Parkes, Henry"

Separate different tags with a comma. To include a comma in your tag, surround the tag with double quotes.

Be the first to add a tag for this edition

Be the first to add this to a list

Comments and reviews

What are comments? Add a comment

No user comments or reviews for this version

Add a comment